ABSTRACT
Background People born preterm (<37 weeks’ gestation) have a potentially adverse cardiac phenotype that progresses with blood pressure elevation. We sought to determine whether preterm-born adults with elevated and stage 1 hypertension exhibit similar cardiac structural and functional remodeling following a 16-week aerobic exercise intervention as their term-born peers.
Methods We conducted an open, parallel, two-arm superiority randomized controlled (1:1) trial in n=203 adults aged 18-35 years old with elevated or stage 1 hypertension. Participants were randomized to a 16-week aerobic exercise intervention targeting three, 60-minute supervised sessions per week at 60-80% peak heart rate (exercise intervention group) or sign-posted to educational materials on hypertension and recommended lifestyle behaviors (control group). In a pre-specified cardiovascular magnetic resonance imaging (CMR) sub-study, CMR was performed on a 3.0-Tesla Siemens scanner to assess left ventricular (LV) and right ventricular (RV) structure and function before and after the 16-week intervention period. Group differences in outcome variables after the intervention were examined using analysis of covariance (ANCOVA) adjusting for baseline outcome variables, sex, and age. Interactions between birth category and intervention effect were investigated by including an interaction term in the intervention ANCOVA analyses.
Results One hundred participants completed CMR scans both at baseline and after the 16-week intervention, with n=47 in the exercise intervention group (n=26 term-born; n=21 preterm-born) and n=53 controls (n=32 term-born; n=21 preterm-born). There was a significantly different response to the exercise intervention between preterm- and term-born participants. In term-born participants, LV mass to end-diastolic volume ratio decreased (adjusted mean difference: -3.43, 95% CI: -6.29,-0.56, interaction term p=0.027) and RV stroke volume index increased (adjusted mean difference: 5.53mL/m2, 95% CI: 2.60,8.47, interaction term p=0.076) for those in the exercise intervention group versus controls. No significant effects were observed for cardiac structural indices in preterm-born participants. In preterm-born participants, LV basal- and mid-ventricular circumferential strain increased (adjusted mean difference: -1.33, 95% CI: -2.07,-0.60, interaction term p=0.057 and adjusted mean difference: -1.54, 95% CI: -2.46,-0.63, interaction term p=0.046, respectively) and RV global longitudinal strain increased (adjusted mean difference=-1.99%, 95% CI=-3.12,-0.87, interaction p=0.053) for those in the exercise intervention group versus controls. No significant effects were observed for myocardial deformation parameters in term-born participants.
Conclusions Aerobic exercise training induces improved myocardial function but not cardiac structure in preterm-born adults.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
The trial was registered on Clinicaltrials.gov on March 30, 2016 (NCT02723552).
Funding Statement
This work was supported by funding from the Wellcome Trust, British Heart Foundation (BHF), the Oxford BHF Centre for Research Excellence, and the National Institute for Health Research Oxford Biomedical Research Centre; a Medical Research Council Programme grant (MR/W003686/1) and St. Hilda?s College Oxford Stipendiary Junior Research Fellowship (W.L.), a BHF Intermediate Research Fellowship (FS/18/3/33292 to A.J.L.); a Wellcome Trust Clinical Research Training Fellowship (105741/Z/14/Z to W. Williamson); and the U.S. Air Force Institute of Technology (O.J.H.). The contents of this paper solely reflect the views of the authors and do not reflect or represent the views of the U.S. Air Force, the Department of Defense, or the U.S. government.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The trial protocol and any subsequent amendments were approved by the University of Oxford as host institution and study sponsor and by the South Central Research Ethics Committee for the National Health Service Health Research Authority (Reference: 16/SC/0016).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* Joint first authors
Data Availability
Data are available upon request.
